Detection of exogenous DNA uptake by murine dendritic cells

This protocol has been developed to measure exogenous DNA uptake by murine dendritic cells (DCs) using supernatant containing cellular debris, which allows for DNA uptake in the absence of transfection reagents. Inhibitors or antibodies that alter the process can be added, and either flow cytometry...

Full description

Saved in:
Bibliographic Details
Published inSTAR protocols Vol. 3; no. 3; p. 101464
Main Authors Celias, Daiana P., de Mingo Pulido, Álvaro, Ruffell, Brian
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 16.09.2022
Elsevier
Subjects
Online AccessGet full text
ISSN2666-1667
2666-1667
DOI10.1016/j.xpro.2022.101464

Cover

More Information
Summary:This protocol has been developed to measure exogenous DNA uptake by murine dendritic cells (DCs) using supernatant containing cellular debris, which allows for DNA uptake in the absence of transfection reagents. Inhibitors or antibodies that alter the process can be added, and either flow cytometry or fluorescent microscopy can be used to measure DNA uptake. This is intended to mimic the exposure of DCs to dying cells in the tumor microenvironment or other pathological conditions of high cellular death. For complete details on the use and execution of this protocol, please refer to de Mingo Pulido et al. (2021). [Display omitted] •In vitro assay to measure exogenous DNA uptake by primary murine dendritic cells•Designed to mimic conditions of high cell death such as those within tumors•DNA uptake occurs spontaneously without the use of transfection reagents•Useful for studying DNA uptake and searching for activators or inhibitors Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. This protocol has been developed to measure exogenous DNA uptake by murine dendritic cells (DCs) using supernatant containing cellular debris, which allows for DNA uptake in the absence of transfection reagents. Inhibitors or antibodies that alter the process can be added, and either flow cytometry or fluorescent microscopy can be used to measure DNA uptake. This is intended to mimic the exposure of DCs to dying cells in the tumor microenvironment or other pathological conditions of high cellular death.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Technical contact
Lead contact
ISSN:2666-1667
2666-1667
DOI:10.1016/j.xpro.2022.101464